Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.
Erkan D, Willis R, Murthy VL, Basra G, Vega J, Ruiz-Limón P, Carrera AL, Papalardo E, Martínez-Martínez LA, González EB, Pierangeli SS. Erkan D, et al. Ann Rheum Dis. 2014 Jun;73(6):1176-80. doi: 10.1136/annrheumdis-2013-203622. Epub 2013 Aug 9. Ann Rheum Dis. 2014. PMID: 23933625 Free PMC article. Clinical Trial.
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Balbi GGM, Ahmadzadeh Y, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Lopez-Pedrera C, Fortin PR, Wahl D, Gerosa M, de Jesús GR, Ji L, Atsumi T, Efthymiou M, Branch DW, Nalli C, Rodriguez Almaraz E, Petri M, Cervera R, Knight JS, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Roubey R, Erkan D, de Andrade DCO; for AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (APS ACTION). Balbi GGM, et al. Among authors: erkan d. Rheumatology (Oxford). 2024 Mar 1;63(3):772-779. doi: 10.1093/rheumatology/kead292. Rheumatology (Oxford). 2024. PMID: 37307082 Free PMC article.
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Zuily S, Clerc-Urmès I, Bauman C, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Michael Belmont H, Zamorano MAA, Fortin P, Ji L, Efthymiou M, Cohen H, Branch DW, Jesus GR, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Vega J, Wahl D, Erkan D; APS ACTION Investigators. Zuily S, et al. Among authors: erkan d. Lupus. 2020 Oct;29(11):1353-1363. doi: 10.1177/0961203320940776. Epub 2020 Jul 23. Lupus. 2020. PMID: 32703117 Free PMC article.
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Sevim E, Bertolaccini ML, Pengo V, Cohen H; APS ACTION. Efthymiou M, et al. Among authors: erkan d. J Thromb Haemost. 2019 Dec;17(12):2069-2080. doi: 10.1111/jth.14596. Epub 2019 Sep 8. J Thromb Haemost. 2019. PMID: 31364274 Free article.
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the "Catastrophic antiphospholipid syndrome registry".
Ponce A, Rodríguez-Pintó I, Basauli JM, Espinosa G, Erkan D, Shoenfeld Y, Cervera R; On Behalf the CAPS Registry Project Group/European Forum on Antiphospholipid Antibodies. Ponce A, et al. Among authors: erkan d. Lupus. 2022 Sep;31(10):1218-1225. doi: 10.1177/09612033221107583. Epub 2022 Jun 10. Lupus. 2022. PMID: 35686348 Review.
Is there a role for immunosuppression in antiphospholipid syndrome?
Sevim E, Willis R, Erkan D. Sevim E, et al. Among authors: erkan d. Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):426-432. doi: 10.1182/hematology.2019000073. Hematology Am Soc Hematol Educ Program. 2019. PMID: 31808842 Free PMC article. Review.
263 results